Avecilla Scott T, Goss Cheryl, Marionneaux Steven M, Wright Donald R, Leiva Tyler D, Tonon Jo-Ann, Smith Katherine M, Maslak Peter
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Rutgers University, New Brunswick, NJ.
Adv Cell Gene Ther. 2018 Sep;1(2). doi: 10.1002/acg2.15. Epub 2018 Aug 13.
CD34+ cell enumeration is a critical parameter used to determine the timing of apheresis collections of hematopoietic progenitor cell products (HPC(A)). Automated hematology analyzers equipped with flow cytometry capabilities may be a solution to the problem of limited access to standard flow cytometry testing.
We compared CD34+ cell enumeration using a reference flow cytometry procedure employing modified International Society of Hematotherapy and Graft Engineering (ISHAGE) analysis with a hematology analyzer /flow cytometer hybrid (CELL DYN (CD)Sapphire) using a sequential gating analysis designed to emulate the ISHAGE gating strategy.
CD34+ cell values obtained from the ISHAGE and CD Sapphire analysis were plotted and compared in a linear regression analysis which showed a high degree of correlation (R=0.96). No statistically significant (p=0.53) differences in CD34+ cell enumeration values were observed between the flow cytometer and automated hematology analyzer using manual analysis schema.
We have demonstrated that an automated hematology analyzer equipped with a flow module can provide CD34+ cell enumeration results in the peripheral blood for clinical decision algorithms without the need for a dedicated flow cytometry laboratory.
CD34+细胞计数是确定造血祖细胞产品(HPC(A))单采时机的关键参数。配备流式细胞术功能的自动血液分析仪可能是解决标准流式细胞术检测受限问题的一种方法。
我们将使用改良的国际血液治疗与移植工程学会(ISHAGE)分析的参考流式细胞术程序进行的CD34+细胞计数,与使用旨在模拟ISHAGE门控策略的序贯门控分析的血液分析仪/流式细胞仪一体机(CELL DYN (CD)Sapphire)进行了比较。
绘制了ISHAGE和CD Sapphire分析获得的CD34+细胞值,并在线性回归分析中进行比较,结果显示高度相关(R=0.96)。使用手动分析模式时,在流式细胞仪和自动血液分析仪之间未观察到CD34+细胞计数值有统计学显著差异(p=0.53)。
我们已经证明,配备流式模块的自动血液分析仪可以为临床决策算法提供外周血中CD34+细胞的计数结果,而无需专门的流式细胞术实验室。